ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 75 filers reported holding ENZON PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $470,000 | -35.6% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $730,000 | -2.4% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $748,000 | -7.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $810,000 | -13.8% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $940,000 | -31.1% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,365,000 | -29.6% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,940,000 | -19.2% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,400,000 | +13.2% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,120,000 | -34.9% | 2,000 | -33.1% | 0.00% | -50.0% |
| Q4 2014 | $3,259,000 | +53.7% | 2,990 | +49.5% | 0.00% | +100.0% |
| Q1 2014 | $2,120,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
| Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
| SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
| Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
| Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
| Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
| Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |
| CSS LLC/IL | 96,572 | $66,000 | 0.00% |